On April 03, 2015 as of the date of publishing the Order of the Ministry of Healthcare of Ukraine “On Amendments to the Order of the Ministry of Healthcare of Ukraine of April 26, 2011 No 237” of 18.12.2014 No 967 became effective the amendments to the Procedure for Importation into Ukraine of Unregistered Medicines, Standardized Samples, and Reagents (hereinafter – the “Procedure for Importation”) approved by the Order of the Ministry of Healthcare of Ukraine of 26.04.2011 No 237.
As a result, as of April 03, 2015 the number of cases when unregistered medicine may be imported into the territory of Ukraine without sales rights is increased.From now onward unregistered medicines may be imported into the territory of Ukraine furthermore:
Import of the above-mentioned medicines unregistered in Ukraine may be carried out by the separate Decision of the Ministry of Healthcare of Ukraine upon availability of the list of documents applicable also in instances of natural calamity, catastrophe, epidemic disease, namely:
Essential amendments were also introduced to the Procedure for Importation of Unregistered Medicines for Clinical Studies.
Formerly, the Procedure established the necessity of obtaining a notification of possibility for importation of unregistered medicines, standardized samples, and reagents into customs territory of Ukraine. In order to import unregistered medicines, designed for conduction of clinical studies, documents had to be filed to the Ministry of Healthcare of Ukraine by the list essentially analogous to the list envisaged for unregistered medicines that were imported for ensuing state registration. Particularly, the list of documents specifically included: letter of acknowledgement of state enterprises “State Expert Center of the Ministry of Healthcare if Ukraine”, copy of a quality certificate and invoice, and document, causing the most lamenting, – copy of a decision on approval of clinical studies program and its conduction.
It is to be recalled, that neither prior nor after the amendments by the Order of the Ministry of Healthcare of Ukraine of 18.12.2014 No 966 to the Procedure for Conduction of Clinical Studies of Medicines and Analysis of Clinical Studies Materials and Model Regulation on Ethics Commission, approved by the Order of the Ministry of Healthcare of Ukraine of 23.09.2009 No 690 (hereinafter – the “Procedure for Clinical Studies”) an approval document under the name of “decision on approval of clinical studies program and its conduction” has not existed. Unfortunately, customs authorities were taking the provision of the Procedure for Importation literally and regardless of the express provision of paragraph 2 subsection в) section 193.1 Article 193 of the Tax Code of Ukraine instead of preferential taxation at the rate of 7% VAT were applying 20% VAT rate.
Amendments to the Procedure were introduced specifically to resolve this stalemate. Hence, as of April 03, 2015 unregistered medicines for conduction of clinical studies may be imported into the territory of Ukraine upon availability of only one document, which is expressly provided for in the Procedure for Conduction of Clinical Studies, - the decision of the Ministry of Healthcare of Ukraine on conduction of clinical studies.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.